3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Burkitt Lymphoma
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
3
Leukemia, Biphenotypic, Acute
3
Smoldering Multiple Myeloma
2
Recurrence
2
Plasmacytoma
2
Neoplasms
2
Breast Neoplasms
2
Blast Crisis
2
Waldenstrom Macroglobulinemia
1
Vomiting
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Nausea
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Gemcitabine
31
Cisplatin
21
pembrolizumab
8
Fluorouracil
6
Oxaliplatin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
durvalumab
4
Taxes
4
Albumin-Bound Paclitaxel
4
pemigatinib
3
infigratinib
3
atezolizumab
3
Specimen Handling
3
Radiosurgery
3
Platinum
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Carboplatin
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
tremelimumab
2
trametinib
2
olaparib
2
ivosidenib
2
derazantinib
2
cobimetinib
2
Trastuzumab
2
Radiotherapy
2
Panitumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Cholangiocarcinoma
×
auricularum
×
Clear all
No trials found.